In fact, PCa with pathologically confirmed neuroendocrine differentiation is characterised by low PSA levels, visceral metastases and loss of RB1 and TP53 genes (suggesting less AR-driven disease)21. The gene discussed is AR; the disease is posterior cortical atrophy.